The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer's disease

Alzheimer's and Dementia: Translational Research and Clinical Interventions

Volumn 3, Issue 3, 2017, Pages 348-359

  Burfeind, Kevin G ^a   Murchison, Charles F ^a   Westaway, Shawn K ^a   Simon, Matthew J ^a   Erten Lyons, Deniz ^a   Kaye, Jeffrey A ^a   Quinn, Joseph F ^a   Iliff, Jeffrey J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Aquaporin 4; Cognitive decline; Cohort study; Genetics; Glymphatic system

Indexed keywords

AQUAPORIN 4;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; EXECUTIVE FUNCTION; FEMALE; GENE FREQUENCY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPATHOLOGY; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; SENILE PLAQUE; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY;

EID: 85020675319     PISSN: None     EISSN: 23528737     Source Type: Journal    
DOI: 10.1016/j.trci.2017.05.001     Document Type: Article

References (38)

1. Tarasoff-Conway, J.M., Carare, R.O., Osorio, R.S., Glodzik, L., Butler, T., Fieremans, E., et al. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol 11 (2015), 457–470.
2. Wildsmith, K.R., Holley, M., Savage, J.C., Skerrett, R., Landreth, G.E., Evidence for impaired amyloid beta clearance in Alzheimer's disease. Alzheimers Res Ther, 5, 2013, 33.
3. Iliff, J.J., Chen, M.J., Plog, B.A., Zeppenfeld, D.M., Soltero, M., Yang, L., et al. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J Neurosci 34 (2014), 16180–16193.
4. Sutphen, C.L., Jasielec, M.S., Shah, A.R., Macy, E.M., Xiong, C., Vlassenko, A.G., et al. Longitudinal cerebrospinal fluid biomarker changes in preclinical Alzheimer disease during middle age. JAMA Neurol 72 (2015), 1029–1042.
5. Patterson, B.W., Elbert, D.L., Mawuenyega, K.G., Kasten, T., Ovod, V., Ma, S., et al. Age and amyloid effects on human central nervous system amyloid-beta kinetics. Ann Neurol 78 (2015), 439–453.
6. Mawuenyega, K.G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J.C., et al. Decreased clearance of CNS amyloid-β in Alzheimer's disease. Science, 330, 2010, 1774.
7. Iliff, J.J., Lee, H., Yu, M., Feng, T., Logan, J., Nedergaard, M., et al. Brain-wide pathway for waste clearance captured by contrast-enhanced MRI. J Clin Invest 123 (2013), 1299–1309.
8. Iliff, J.J., Wang, M., Liao, Y., Plogg, B.A., Peng, W., Gundersen, G.A., et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med, 4, 2012, 147ra11.
9. Xu, Z., Xiao, N., Chen, Y., Huang, H., Marshall, C., Gao, J., et al. Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Abeta accumulation and memory deficits. Mol Neurodegener, 10, 2015, 58.
10. Kress, B.T., Iliff, J.J., Xia, M., Wang, M., Wei, H.S., Zeppenfeld, D., et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol 76 (2014), 845–861.
11. Zeppenfeld, D.M., Simon, M., Haswell, J.D., D'Abreo, D., Murchison, C., Quinn, J.F., et al. Association of perivascular localization of aquaporin-4 with cognition and Alzheimer disease in aging brains. JAMA Neurol 74 (2017), 91–99.
12. Eide, P.K., Ringstad, G., MRI with intrathecal MRI gadolinium contrast medium administration: a possible method to assess glymphatic function in human brain. Acta Radiol Open, 4, 2015 2058460115609635.
13. Opdal, S.H., Vege, A., Stray-Pedersen, A., Rognum, T.O., Aquaporin-4 gene variation and sudden infant death syndrome. Pediatr Res 68 (2010), 48–51.
14. Kleffner, I., Bungeroth, M., Schiffbauer, H., Schabitz, W.R., Ringelstein, E.B., Kuhlenbaumer, G., The role of aquaporin-4 polymorphisms in the development of brain edema after middle cerebral artery occlusion. Stroke 39 (2008), 1333–1335.
15. Yadav, B.K., Oh, S.Y., Kim, N.K., Shin, B.S., Association of rs2075575 and rs9951307 polymorphisms of AQP-4 gene with leukoaraiosis. J Stroke Cerebrovasc Dis 23 (2014), 1199–1206.
16. Dardiotis, E., Paterakis, K., Tsivgoulis, G., Tsintou, M., Hadjigeorgiou, G.F., Dardioti, M., et al. AQP4 tag single nucleotide polymorphisms in patients with traumatic brain injury. J Neurotrauma 31 (2014), 1920–1926.
17. Payami, H., Grimslid, H., Oken, B., Camicioli, R., Sexton, G., Dame, A., et al. A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype. Am J Hum Genet 60 (1997), 948–956.
18. Kaye, J.A., Maxwell, S.A., Mattek, N., Hayes, T.L., Dodge, H., Pavel, M., et al. Intelligent Systems for Assessing Aging Changes: Home-Based, Unobtrusive, and Continuous Assessment of Aging. J Gerontol B Psychol Sci Soc Sci 66B (2011), i180–i190.
19. Kaye, J., Michael, Y., Calvert, J., Leahy, M., Crawford, D., Kramer, P., Exceptional Brain Aging in a Rural Population-Based Cohort. J Rural Health 25 (2009), 320–325.
20. Howieson, D.B., Holm, L.A., Kaye, J.A., Oken, B.S., Howieson, J., Neurologic function in the optimally healthy oldest old. Neuropsychological evaluation. Neurology 43 (1993), 1882–1886.
21. McKhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack, C.R. Jr., Kawas, C.H., et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7 (2011), 263–269.
22. Green, M.S., Kaye, J.A., Ball, M.J., The Oregon brain aging study: neuropathology accompanying healthy aging in the oldest old. Neurology 54 (2000), 105–113.
23. Consensus report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer's Disease”. The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group. Neurobiol Aging 19 (1998), 109–116.
24. Beekly, D.L., Ramos, E.M., van Belle, G., Deitrich, W., Clark, A.D., Jacka, M.E., et al. The National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database. Alzheimer Dis Assoc Disord 18 (2004), 270–277.
25. Folstein, M.F., Folstein, S.E., McHugh, P.R., “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975), 189–198.
26. O'Bryant, S.E., Waring, S.C., Cullum, C.M., Hall, J., Lacritz, L., Massman, P.J., et al., Texas Alzheimer's Research Consortium. Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study. Arch Neurol 65 (2008), 1091–1095.
27. Wechsler, D., Wechsler Memory Scale–Revised. 1987, Pscyhological Corporation, New York.
28. Wechsler, D., The Measurement and Appraisal of Adult Intelligence. 1st ed., 1939, Williams and Wilkins Corporation, Baltimore.
29. Dikmen, S.S., Heaton, R.K., Grant, I., Temkin, N.R., Test–retest reliability and practice effects of expanded Halstead–Reitan Neuropsychological Test Battery. J Int Neuropsychol Soc 5 (1999), 346–356.
30. Brenowitz, W.D., Keene, C.D., Hawes, S.E., Hubbard, R.A., Longstreth, W.T. Jr., Woltjer, R.L., et al. Alzheimer's disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples. Neurobiol Aging 53 (2017), 83–92.
31. Team, R.C., R: A Language and Environment for Statistical Computing. 2016, R Foundation for Statistical Computing, Vienna, Austria Available at: https://www.R-project.org Accessed May 30, 2017.
32. Bates, D., Mächler, M., Bolker, B., Walker, S., Fitting Linear Mixed-Effects Models Using lme4. J Stat Softw, 1, 2015, 2015.
33. de Groot, V., Beckerman, H., Lankhorst, G.J., Bouter, L.M., How to measure comorbidity. a critical review of available methods. J Clin Epidemiol 56 (2003), 221–229.
34. Parmelee, P.A., Thuras, P.D., Katz, I.R., Lawton, M.P., Validation of the Cumulative Illness Rating Scale in a geriatric residential population. J Am Geriatr Soc 43 (1995), 130–137.
35. Linn, B.S., Linn, M.W., Gurel, L., Cumulative illness rating scale. J Am Geriatr Soc 16 (1968), 622–626.
36. Nagelhus, E.A., Ottersen, O.P., Physiological roles of aquaporin-4 in brain. Physiol Rev 93 (2013), 1543–1562.
37. Erten-Lyons, D., Jacobson, A., Kramer, P., Grupe, A., Kaye, J., The FAS gene, brain volume, and disease progression in Alzheimer's disease. Alzheimers Dement 6 (2010), 118–124.
38. Zeppenfeld, D., Simon, M., Haswell, J.D., D'Abreo, D., Murchison, C., Quinn, J.F., et al. Preservation of perivascular aquaporin-4 localization in the cognitively-healthy elderly. JAMA Neurol 74 (2017), 91–99.